Curaleaf keeps its Aurora takeover offer open as Organigram proposes a higher C$7.80‑per‑share bid
Curaleaf Holdings reiterated that its enhanced premium bid dated October 6, 2026 to acquire all Aurora Cannabis shares remains outstanding. Aurora’s board has accepted an alternative offer from Organigram Global of C$7.80 per share, valuing the transaction at roughly C$561 million and backed by British American Tobacco. Curaleaf said its offer provides greater long‑term value and will stay open until December 4, 2026 while it reviews the competing proposal.
Why it matters
The higher Organigram offer, a 21% premium to Curaleaf’s price, could shift shareholder support away from Curaleaf, affecting the likelihood of a Curaleaf‑led transaction. Investors in both Curaleaf (CURLF) and Aurora (ACB) should monitor the outcome as it will determine which bid, if any, closes.
Key facts
- 1Curaleaf’s enhanced premium bid to purchase all outstanding Aurora common shares was dated October 6, 2026. stocktitan.net
- 2Organigram’s offer values Aurora at C$7.80 per share, or roughly C$561 million in total. businessofcannabis.com
- 3Organigram’s price represents a 21% premium over Curaleaf’s bid price. securities.io
- 4Aurora’s board has unanimously recommended that shareholders accept Organigram’s offer. businessofcannabis.com
- 5Curaleaf said its offer will remain open until December 4, 2026. businessofcannabis.com
- 6British American Tobacco is contributing C$187.5 million to fund the cash portion of Organigram’s deal. businessofcannabis.com
Summary written by AlphAI AI Desk from 7 of 7 sources. Not investment advice. Figures are as stated by the linked sources.